These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19426225)

  • 1. Immunoregulation by tumor necrosis factor superfamily member LIGHT.
    Wang Y; Zhu M; Miller M; Fu YX
    Immunol Rev; 2009 May; 229(1):232-43. PubMed ID: 19426225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.
    Steinberg MW; Cheung TC; Ware CF
    Immunol Rev; 2011 Nov; 244(1):169-87. PubMed ID: 22017438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
    Cai G; Freeman GJ
    Immunol Rev; 2009 May; 229(1):244-58. PubMed ID: 19426226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.
    Ware CF
    Immunol Rev; 2008 Jun; 223():186-201. PubMed ID: 18613837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIGHT/HVEM/LTβR interaction as a target for the modulation of the allogeneic immune response in transplantation.
    del Rio ML; Schneider P; Fernandez-Renedo C; Perez-Simon JA; Rodriguez-Barbosa JI
    Am J Transplant; 2013 Mar; 13(3):541-51. PubMed ID: 23356438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model.
    Pierer M; Schulz A; Rossol M; Kendzia E; Kyburz D; Haentzschel H; Baerwald C; Wagner U
    J Immunol; 2009 Mar; 182(5):3139-45. PubMed ID: 19234211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression.
    Stringhini M; Mock J; Fontana V; Murer P; Neri D
    MAbs; 2021; 13(1):1868066. PubMed ID: 33404287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
    Cheung TC
    Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
    Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
    J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
    Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
    J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling.
    Cohavy O; Zhou J; Ware CF; Targan SR
    J Immunol; 2005 Jan; 174(2):646-53. PubMed ID: 15634882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production.
    Pasero C; Barbarat B; Just-Landi S; Bernard A; Aurran-Schleinitz T; Rey J; Eldering E; Truneh A; Costello RT; Olive D
    Eur J Immunol; 2009 Sep; 39(9):2502-14. PubMed ID: 19701890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection.
    Stanley AC; de Labastida Rivera F; Haque A; Sheel M; Zhou Y; Amante FH; Bunn PT; Randall LM; Pfeffer K; Scheu S; Hickey MJ; Saunders BM; Ware C; Hill GR; Tamada K; Kaye PM; Engwerda CR
    PLoS Pathog; 2011 Oct; 7(10):e1002279. PubMed ID: 21998581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting.
    Pasero C; Truneh A; Olive D
    Curr Mol Med; 2009 Sep; 9(7):911-27. PubMed ID: 19860669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT.
    Holmes TD; Wilson EB; Black EV; Benest AV; Vaz C; Tan B; Tanavde VM; Cook GP
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):E5688-96. PubMed ID: 25512551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic blockade of LIGHT interaction with herpesvirus entry mediator and lymphotoxin β receptor attenuates in vivo cytotoxic allogeneic responses.
    del Rio ML; Fernandez-Renedo C; Scheu S; Pfeffer K; Shintani Y; Kronenberg M; Chaloin O; Schneider P; Rodriguez-Barbosa JI
    Transplantation; 2014 Dec; 98(11):1165-74. PubMed ID: 25226173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of the TNF superfamily member LIGHT/TNFSF14 and its receptors (HVEM and LTßR) in patients with systemic sclerosis.
    Gindzienska-Sieskiewicz E; Distler O; Reszec J; Jordan S; Bielecki P; Sieskiewicz A; Sulik A; Lukasik M; Bielecki M; Kowal K; Kowal-Bielecka O
    Rheumatology (Oxford); 2019 Mar; 58(3):502-510. PubMed ID: 30508197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
    Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
    J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cellular expression of LIGHT and its receptors in early gestation human placentas.
    Gill RM; Coleman NM; Hunt JS
    J Reprod Immunol; 2007 Jun; 74(1-2):1-6. PubMed ID: 17010447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis.
    De Trez C; Ware CF
    Cytokine Growth Factor Rev; 2008; 19(3-4):277-84. PubMed ID: 18511331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.